SAGENT PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/12c5ea9c-6bde-49c8-8d4e-32d2e2ac1b7a/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-44.5M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-495377 |
| FY 2014 | $19.0M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-093810 |
| FY 2013 | $31.4M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-089369 |
| FY 2012 | $-15.5M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-112600 |
| FY 2011 | $-21.7M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-139875 |
| FY 2010 | $-22.6M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-139875 |
| FY 2009 | $-30.1M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-139875 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SAGENT PHARMACEUTICALS, INC. — all facts · Revenue · Net Income